2019
DOI: 10.18295/squmj.2018.18.04.015
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Combination Calcipotriol plus Betamethasone Dipropionate Gel in the Treatment of Moderate-to-Severe Scalp Seborrhoeic Dermatitis

Abstract: Objectives: This study aimed to investigate the off-label use of a combination calcipotriol plus betamethasone dipropionate (CBD) gel in the treatment of moderate-to-severe scalp seborrhoeic dermatitis (SSD). Methods: This retrospective study involved 32 patients with SSD who were prescribed CBD gel at the Subang Jaya Medical Centre, Selangor, Malaysia, between January 2016 and December 2017. The Physician Global Assessment Scale was used to assess disease severity. Itching/discomfort was evaluated using a vis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…is study showed that the combination of betamethasone Dermatology Research and Practice and calcipotriol is useful in the treatment of moderate to severe scalp disease. However, the study was quasi-experimental and retrospective [20]. e observed discrepancy between studies can be due to variable experimental design, unknown status of basal serum 25(OH)D level, and disease severity.…”
Section: Discussionmentioning
confidence: 99%
“…is study showed that the combination of betamethasone Dermatology Research and Practice and calcipotriol is useful in the treatment of moderate to severe scalp disease. However, the study was quasi-experimental and retrospective [20]. e observed discrepancy between studies can be due to variable experimental design, unknown status of basal serum 25(OH)D level, and disease severity.…”
Section: Discussionmentioning
confidence: 99%
“…The data in studies on the use of topical vit D analogs in the treatment of SD are still contradictory. While beneficial results are obtained in some studies, others are not found to be effective enough 32 - 37 .…”
Section: Discussionmentioning
confidence: 99%
“…In an early Japanese open trial, application of tacalcitol (1,24dihydroxycholecalciferol) twice daily produced a 73% marked improvement in facial SD [94]. Basak and Ergin [95] divided sixty patients into two equal groups and treated with either calcipotriol (50 µg/mL) or betamethasone 17-valerate (1 mg/mL) solution twice daily for four weeks. Although both treatments displayed successful results, the betamethasone 17-valerate treatment was superior to that of calcipotriol treatment in all aspects.…”
Section: Seborrheic Dermatitismentioning
confidence: 99%